502 results
Page 5 of 26
SC TO-C
EX-99.1
c79za6
15 Dec 20
Information about tender offer
6:29am
8-K
EX-99.1
qcq9d54ep95tqt
27 Oct 20
Lilly Reports Third-Quarter Financial Results, Updates Guidance
7:50am
424B2
9stpza5yk75vfd7bl
21 Aug 20
Prospectus for primary offering
4:05pm
424B2
8dkgfp
20 Aug 20
Prospectus for primary offering
9:28am
8-K
EX-99.1
huk8s7q btz6pqeka
30 Jul 20
Lilly Reports Second-Quarter Financial Results, Raises EPS Guidance
7:03am
424B5
czomtmy0dfhp 6524x
27 Apr 20
Prospectus supplement for primary offering
4:07pm
424B5
oig2 06c0s5krjrhyh
24 Apr 20
Prospectus supplement for primary offering
8:49am
8-K
EX-99.1
awpb7
23 Apr 20
Lilly Reports Strong First-Quarter Financial Results, Adjusts EPS Guidance
8:02am
DEFA14A
wdtfmezo
20 Mar 20
Additional proxy soliciting materials
10:43am
8-K
EX-99.1
rc7k2 e9573msk
30 Jan 20
Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition
6:29am
SC TO-T
EX-99
xbsdqtz
22 Jan 20
Third party tender offer statement
7:04am
SC TO-C
EX-99.1
458igmpj vwt03v6e
10 Jan 20
Information about tender offer
6:56am
8-K
EX-99.1
qsdjck f1p
17 Dec 19
Lilly Announces 2020 Financial Guidance, Updates 2019 Guidance
8:46am